SC 13G/A: UroGen Pharma Ltd.

AI Summary

SC 13G/A filing by UroGen Pharma Ltd..

Risk Assessment

Risk Level: low

Filing Documents

• urgna1_111224.htm (SC 13G/A) — 35KB
• 0001085146-24-005686.txt ( ) — 36KB

(a)

ITEM 1(a). NAME OF ISSUER: UroGen Pharma Ltd.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 9 HaTaAsiya St. RaAnana Israel 4365007

(a)

ITEM 2(a). NAME OF PERSON FILING: Cowen and Company, LLC Cowen Financial Products LLC

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: Cowen and Company LLC: 599 Lexington Ave., New York, NY 10022 Cowen Financial Products LLC: 599 Lexington Ave., New York, NY 10022

(c)

ITEM 2(c). CITIZENSHIP: Cowen and Company LLC: Delaware Cowen Financial Products LLC: Delaware

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Ordinary Shares

(e)

ITEM 2(e). CUSIP NUMBER: BZ7PJQ1 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. OWNERSHIP (a) Amount beneficially owned: Cowen and Company LLC: 0 Cowen Financial Products LLC: 1,796,589 (b) Percent of class: Cowen and Company LLC: 0% Cowen Financial Products LLC: 4.3% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen and Company LLC: 0 Cowen Financial Products LLC: 1,796,589 (ii) shared power to vote or to direct the vote: (iii) sole power to dispose or direct the disposition of: Cowen and Company LLC: 0 Cowen Financial Products LLC: 1,796,589 (iv) shared power to dispose or to direct the disposition of: ITEM 5. OWNERSHIP OF FIVE PERCENT O